Join us in Boston this June and Gain Critical Perspective on the Challenges and Opportunities Facing All Players in the Evolving Global Medical Device Market
Elsevier Business Intelligence, publisher of "The Gray Sheet," IN VIVO, START-UP and MedTech Insight is pleased to announce IN3 Medical Device 360° Boston.
In today's increasingly complex, globally driven healthcare environment, your business requires up-to-the-minute market expertise on all the critical factors impacting your success. EBI, as a leader in the field of healthcare industry data and analysis, gives medical technology executives a full 360° view of their market, opportunities and challenges. The upcoming IN³ Medical Device 360° Boston conference - EBI's 47th IN³ event and always one of the best-attended device investment and partnering events of the year - is a true reflection of this 360° spirit.
This must-attend conference, taking place in the hub of device investment and innovation on the US East Coast, will bring together early-, mid- and late-stage start-ups from around the world seeking funding or strategic partnership with top-tier strategic and VC investors, and industry thought leaders examining the most pressing issues facing our global industry in 2012 and beyond. The two-day program will include a variety of insightful and interactive panel discussions, an evening reception/presenter exhibition, as well as plenty of networking opportunities.
IN3 Medical Device 360° Boston will benefit all players in the device space:
As an Early-, Mid- or Late-Stage Start-Up Seeking Investment or Partnership: Present to our audience of key decision makers in investment, corporate business development and venture capital, and advance your company to the next level. Apply to Present.
As an Investor: Meet the management teams and hear pitches from more than 35 carefully selected, innovative start-ups poised to transform existing markets or create new ones.
As a Mid-Size Medical Device Company: Learn about key drivers and limiters to your growing business, meet potential partners to help you through clinical trials and onto the market, and assess acquisition targets.
As a Large Medical Device Company: Assess a myriad of opportunities to expand your company's portfolio and ensure a healthy pipeline in 2012 and beyond.
As a Service Provider: Gain exposure to innovators and market leaders who are seeking quality partners and outsourcing to bring their companies and products to the next level.
